Connect with us

Health

Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…

Published

on

Article feature image

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Orlando Sentinel’s editorial board implores Floridians to get vaccinated | TheHill – The Hill
Article feature image
Coronavirus: California man who made fun of vaccine dies of virus – Boston 25 News